Zygomycosis future or investigational therapies

Zygomycosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Zygomycosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Zygomycosis future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Zygomycosis future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Zygomycosis future or investigational therapies
CDC on Zygomycosis future or investigational therapies
Zygomycosis future or investigational therapies in the news
Blogs on Zygomycosis future or investigational therapies
Directions to Hospitals Treating Zygomycosis
Risk calculators and risk factors for Zygomycosis future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

For pythiosis and lagenidiosis, a new drug targeting water moulds called caspofungin is available, but it is very expensive.

References

Template:WikiDoc Sources